Sandoz Group AG
Research Sandoz Group AG (D8Y0) on Bullrun: market cap EUR 32.67B, P/E 41.3, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerD8Y0
- ExchangeF
- CountrySwitzerland
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 32.67B
- P/E41.3
- Dividend yield1.2%
- Financial periodFY2025
- RevenueEUR 11.16B
- Revenue growth7.4%
- Net incomeEUR 914.00M
- Free cash flowEUR 810.00M
- Gross margin47.4%
Valuation Snapshot
latest market cap is EUR 32.67B; P/E is 41.3; dividend yield is 1.2%.
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms.
Frequently asked questions
What is Sandoz Group AG's market cap?
Sandoz Group AG's market capitalization is EUR 32.67B.
What is Sandoz Group AG's P/E ratio?
Sandoz Group AG's price-to-earnings (P/E) ratio is 41.3.
Does Sandoz Group AG pay a dividend?
Sandoz Group AG has a dividend yield of 1.2%.
What does Sandoz Group AG do?
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology,...